Skip to main content
OpenTrials

Clinical trial condition

Kidney Neoplasms

Explore clinical trials studying Kidney Neoplasms. Study availability and eligibility vary by location and protocol.

1,164 public trials 220 recruiting studies
Refine in advanced search Browse all conditions

Kidney Neoplasms trial results

Recruiting

A Clinical Study of Belzutifan (MK-6482) and Zanzalintinib in People With Renal Cell Carcinoma (RCC) (LITESPARK-034/LS-034/MK-6482-034)

NCT07489495

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +13 more
Locations
  • Northwest Georgia Oncology Centers, a Service of Wellstar Cobb Hospital ( Site 0102) Marietta, Georgia, United States
  • The West Clinic, P.C. ( Site 0115) Germantown, Tennessee, United States
  • Centro Oncologico Korben ( Site 0254) CABA, Buenos Aires, Argentina
  • Hospital Italiano de Buenos Aires ( Site 0253) Ciudad de Buenos Aires, Buenos Aires, Argentina
View all 92 locations
View Trial Details
Recruiting

DESTINY-PANTUMOUR04

NCT07124000

Conditions
Adenocarcinoma, Adenocarcinoma (NOS), Adnexal Diseases, +116 more
Locations
  • Research Site Birmingham, Alabama, United States
  • Research Site Bullhead City, Arizona, United States
  • Research Site Casa Grande, Arizona, United States
  • Research Site San Diego, California, United States
View all 18 locations
View Trial Details
Recruiting

WIRE - Novel Treatments in Renal Cell Cancer

NCT03741426

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations
  • Addenbrooke's Hospital Cambridge, England, United Kingdom
  • Western General Hospital, Edinburgh, EH4 2XU Edinburgh, United Kingdom
  • Royal Devon University Healthcare NHSFT, Exeter, EX2 5DW Exeter, United Kingdom
  • Beatson Institute for Cancer Research Glasgow, United Kingdom
View Trial Details
Recruiting

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

NCT03866382

Conditions
Adenocarcinoma, Bladder Adenocarcinoma, Bladder Clear Cell Adenocarcinoma, +71 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
View all 581 locations
View Trial Details
Recruiting

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

NCT06047379

Conditions
Adenocarcinoma, Astrocytoma, Brain Diseases, +93 more
Locations
  • Precision NextGen Oncology Beverly Hills, California, United States
  • OPN Healthcare, Inc Glendale, California, United States
  • University of Southern California Los Angeles, California, United States
  • MDR Core Network Boynton Beach, Florida, United States
View Trial Details
Recruiting

Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell Tumor

NCT04616560

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Desmoplastic Small Round Cell Tumor, Female Urogenital Diseases, +25 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Children's Hospital of Orange County Orange, California, United States
  • Lucile Packard Children's Hospital Stanford University Palo Alto, California, United States
View all 30 locations
View Trial Details
Recruiting

A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Other Agents in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208)

NCT07293351

Conditions
Adenocarcinoma, Advanced Renal Cell Carcinoma (RCC), Carcinoma, +14 more
Locations
  • Local Institution - 0178 Palo Alto, California, United States
  • Local Institution - 0117 New Haven, Connecticut, United States
  • Sibley Memorial Hospital Washington D.C., District of Columbia, United States
  • Local Institution - 0177 Miami, Florida, United States
View all 95 locations
View Trial Details
Recruiting

Trial of Zanzalintinib (XL092) in Combination With Immunotherapy in Patients Who Progress on Adjuvant Therapy in Clear Cell RCC

NCT06863311

Conditions
Adenocarcinoma, Advanced Renal Cell Carcinoma, Carcinoma, +16 more
Locations
  • University of California San Diego La Jolla, California, United States
  • Indiana University Melvin and Bren Simon Comprehensive Cancer Center Indianapolis, Indiana, United States
  • Washington University School of Medicine St Louis, Missouri, United States
  • Columbia University Irving Medical Center New York, United States
View Trial Details

Related conditions